Chapter 1. Molecular Diagnostics Market – Scope & Methodology
1.1 Market Segmentation
1.2 Scope, Assumptions & Limitations
1.3 Research Methodology
1.4 Primary Sources
1.5 Secondary Sources
Chapter 2. Molecular Diagnostics Market – Executive Summary
2.1 Market Size & Forecast – (2022 – 2030) ($M/$Bn)
2.2 Key Trends & Insights
2.2.1 Demand Side
2.2.2 Supply Side
2.3 Attractive Investment Propositions
2.4 COVID-19 Impact Analysis
Chapter 3. Molecular Diagnostics Market – Competition Scenario
3.1 Market Share Analysis & Company Benchmarking
3.2 Competitive Strategy & Development Scenario
3.3 Competitive Pricing Analysis
3.4 Supplier-Distributor Analysis
Chapter 4. Molecular Diagnostics Market Entry Scenario
4.1 Regulatory Scenario
4.2 Case Studies – Key Start-ups
4.3 Customer Analysis
4.4 PESTLE Analysis
4.5 Porters Five Force Model
4.5.1 Bargaining Power of Suppliers
4.5.2 Bargaining Powers of Customers
4.5.3 Threat of New Entrants
4.5.4 Rivalry among Existing Players
4.5.5 Threat of Substitutes
Chapter 5. Molecular Diagnostics Market – Landscape
5.1 Value Chain Analysis – Key Stakeholders Impact Analysis
5.2 Market Drivers
5.3 Market Restraints/Challenges
5.4 Market Opportunities
Chapter 6. Molecular Diagnostics Market – By Product
6.1 Introduction/Key Findings
6.2 Reagents and Kits
6.3 Instruments
6.4 Software &Services
6.5 Y-O-Y Growth trend Analysis By Product
6.6 Absolute $ Opportunity Analysis By Product, 2023-2030
Chapter 7. Molecular Diagnostics Market – By Technology
7.1 Introduction/Key Findings
7.2 Polymerase Chain Reactions (PCR)
7.3 Hybridization
7.4 DNA Sequencing
7.5 Microarray
7.6 Isothermal Nucleic Acid Amplification Technology (INAAT)
7.7 Others
7.8 Y-O-Y Growth trend Analysis By Technology
7.9 Absolute $ Opportunity Analysis By Technology, 2023-2030
Chapter 8. Molecular Diagnostics Market – By Application
8.1 Introduction/Key Findings
8.2 Infectious Diseases Diagnostics
8.3 Oncology
8.4 Genetic Testing
8.5 Blood Screening
8.6 Others
8.7 Y-O-Y Growth trend Analysis By Application
8.8 Absolute $ Opportunity Analysis By Application, 2023-2030
Chapter 9. Molecular Diagnostics Market – By End Users
9.1 Introduction/Key Findings
9.2 Hospitals
9.3 Laboratories
9.4 Others
9.5 Y-O-Y Growth trend Analysis By End Users
9.6 Absolute $ Opportunity Analysis By End Users, 2023-2030
Chapter 10. Molecular Diagnostics Market, By Geography – Market Size, Forecast, Trends & Insights
10.1 North America
10.1.1 By Country
10.1.1.1 U.S.A.
10.1.1.2 Canada
10.1.1.3 Mexico
10.1.2 By Product
10.1.2.1 By Technology
10.1.3 By Application
10.1.4 Countries & Segments - Market Attractiveness Analysis
10.2 Europe
10.2.1 By Country
10.2.1.1 U.K
10.2.1.2 Germany
10.2.1.3 France
10.2.1.4 Italy
10.2.1.5 Spain
10.2.1.6 Rest of Europe
10.2.2 By Product
10.2.3 By Technology
10.2.4 By Application
10.2.5 By By End Users
10.2.6 Countries & Segments - Market Attractiveness Analysis
10.3 Asia Pacific
10.3.1 By Country
10.3.1.1 China
10.3.1.2 Japan
10.3.1.3 South Korea
10.3.1.4 India
10.3.1.5 Australia & New Zealand
10.3.1.6 Rest of Asia-Pacific
10.3.2 By Product
10.3.3 By Technology
10.3.4 By Application
10.3.5 By By End Users
10.3.6 Countries & Segments - Market Attractiveness Analysis
10.4 South America
10.4.1 By Country
10.4.1.1 Brazil
10.4.1.2 Argentina
10.4.1.3 Colombia
10.4.1.4 Chile
10.4.1.5 Rest of South America
10.4.2 By Product
10.4.3 By Technology
10.4.4 By Application
10.4.5 By By End Users
10.4.6 Countries & Segments - Market Attractiveness Analysis
10.5 Middle East & Africa
10.5.1 By Country
10.5.1.1 United Arab Emirates (UAE)
10.5.1.2 Saudi Arabia
10.5.1.3 Qatar
10.5.1.4 Israel
10.5.1.5 South Africa
10.5.1.6 Nigeria
10.5.1.7 Kenya
10.5.1.8 Egypt
10.5.1.9 Rest of MEA
10.5.2 By Product
10.5.3 By Technology
10.5.4 By Application
10.5.5 By By End Users
10.5.6 Countries & Segments - Market Attractiveness Analysis
Chapter 11. Molecular Diagnostics Market – Company Profiles – (Overview, Product Portfolio, Financials, Strategies & Developments)
11.1 Roche Diagnostics
11.2 Qiagen
11.3 Thermo Fisher Scientific
11.4 Abbott Laboratories
11.5 Bio-Rad Laboratories
11.6 Hologic, Inc.
11.7 Danaher Corporation
11.8 Siemens Healthineers
11.9 Agilent Technologies
11.10 Grifols
11.11 Myriad Genetics
2850
5250
4500
1800
Frequently Asked Questions
The Global Molecular Diagnostics Market was valued at USD 11.6 billion in 2022 and is projected to reach a market size of USD 22.5 billion by the end of 2030, indicating a substantial CAGR of 8.633% during the forecast period of 2023-2030.
Advancements in technology, the rising prevalence of chronic diseases, personalized medicine and targeted therapies, and government initiatives and funding are key drivers.
The market is segmented into polymerase chain reaction, next-generation sequencing, microarrays, isothermal nucleic acid amplification technology, and others.
North America dominates the Global Molecular Diagnostics Market.
Roche Diagnostics, Qiagen, Thermo Fisher Scientific, Abbott Laboratories, Bio-Rad Laboratories, Hologic, Inc., Danaher Corporation, Siemens Healthineers, Agilent Technologies, Grifols, and Myriad Genetics are among the key players in the market.